Griffiths C E, Esmann J, Fisher G J, Voorhees J J, Nickoloff B J
Department of Dermatology, University of Michigan Medical Center, Ann Arbor 48109-0602.
Br J Dermatol. 1990 Mar;122(3):333-42. doi: 10.1111/j.1365-2133.1990.tb08281.x.
There is growing evidence that keratinocyte (KC) intercellular adhesion molecule-I (ICAM-I) expression is involved in the epidermal trafficking of T lymphocytes. To further characterize the molecular basis of KC ICAM-I expression, the detailed kinetics of induction by gamma interferon (IFN-gamma), as well as the phorbol ester, 12-O tetradecanoylphorbol-13-acetate (TPA), were studied. This study reports that KCs express both the class II major histocompatibility antigen (HLA-DR) and ICAM-I in response to IFN-gamma, although the response is distinctive for each molecule. Also, TPA induces ICAM-I, but not HLA-DR expression, whilst the protein kinase inhibitor, H7, blocks the TPA, but not the IFN-gamma-mediated response. The results provide a molecular basis whereby non-cytokine-mediated stimuli (e.g. TPA) alter KC signal transduction events involving protein kinase-C (PK-C) and thereby generate such immunologically relevant events as ICAM-I expression. Thus, KCs may be targets for both T-cell derived cytokines (e.g. IFN-gamma), and non-cytokine TPA-like molecules which stimulate PK-C. Induction of ICAM-I by either mechanism would be capable of instigating intraepidermal T-cell trafficking.
越来越多的证据表明,角质形成细胞(KC)细胞间黏附分子 -I(ICAM-I)的表达参与了T淋巴细胞的表皮转运。为了进一步阐明KC ICAM-I表达的分子基础,我们研究了γ干扰素(IFN-γ)以及佛波酯12-O十四酰佛波醇-13-乙酸酯(TPA)诱导的详细动力学过程。本研究报道,KC对IFN-γ应答时会表达II类主要组织相容性抗原(HLA-DR)和ICAM-I,尽管对每个分子的应答有所不同。此外,TPA可诱导ICAM-I表达,但不诱导HLA-DR表达,而蛋白激酶抑制剂H7可阻断TPA介导的应答,但不阻断IFN-γ介导的应答。这些结果提供了一个分子基础,即非细胞因子介导的刺激(如TPA)可改变涉及蛋白激酶C(PK-C)的KC信号转导事件,从而产生如ICAM-I表达等免疫相关事件。因此,KC可能是T细胞衍生细胞因子(如IFN-γ)和刺激PK-C的非细胞因子类TPA分子的作用靶点。通过这两种机制诱导ICAM-I均能够促使表皮内T细胞的转运。